Bachem Holding AG (LON:0QND)
London
· Delayed Price · Currency is GBP · Price in CHF 47.06
-0.70 (-1.47%)
At close: Apr 17, 2025
Bachem Holding AG Revenue
In the year 2024, Bachem Holding AG had annual revenue of 605.26M CHF with 4.84% growth. Bachem Holding AG had revenue of 364.95M in the half year ending December 31, 2024, with 22.94% growth.
Revenue
605.26M CHF
Revenue Growth
+4.84%
P/S Ratio
6.29
Revenue / Employee
274.25K CHF
Employees
2,207
Market Cap
3.36B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 605.26M | 27.94M | 4.84% |
| Dec 31, 2023 | 577.32M | 45.58M | 8.57% |
| Dec 31, 2022 | 531.74M | 28.51M | 5.66% |
| Dec 31, 2021 | 503.23M | 101.24M | 25.18% |
| Dec 31, 2020 | 402.00M | 88.28M | 28.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Bachem Holding AG News
- 7 weeks ago - Bachem Holding AG (BCHMF) (Q4 2024) Earnings Call Highlights: Surpassing Financial Goals Amid ... - GuruFocus
- 7 weeks ago - Full Year 2024 Bachem Holding AG Earnings Call Transcript - GuruFocus